Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma

被引：25

作者：

Krishnan, Ganapathy ^{[1
]}

D'Silva, Karl ^{[1
]}

Al-Janadi, Anas ^{[1
]}

机构：

[1] Michigan State Univ, Dept Internal Med, Div Hematol & Oncol, E Lansing, MI 48824 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 14期

关键词：

D O I：

10.1200/JCO.2007.14.7603

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2406 / 2408

页数：4

共 13 条

[1] Tumour lysis syndrome with acute renal failure during imatinib therapy [J].

Ali, Ridvan ;

Ozkalemkas, Fahir ;

Ozkan, Atilla ;

Ozcelik, Tulay ;

Ozkocaman, Vildan ;

Akdag, Ibrahim ;

Ozan, Ulku .

LEUKEMIA RESEARCH, 2007, 31 (04) :573-574

[2] Tumour lysis syndrome: new therapeutic strategies and classification [J].

Cairo, MS ;

Bishop, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (01) :3-11

[3] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].

Cunningham, D ;

Humblet, Y ;

Siena, S ;

Khayat, D ;

Bleiberg, H ;

Santoro, A ;

Bets, D ;

Mueser, M ;

Harstrick, A ;

Verslype, C ;

Chau, I ;

Van Cutsem, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345

[4]

Lenz HJ, 2005, J CLIN ONCOL, V23, p255S

[5]

Lenz HJ, 2004, J CLIN ONCOL, V22, p247S

[6]

MOURAD YA, 2003, HEMATOL J, V4, P222

[7] Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia [J].

Pou, M ;

Saval, N ;

Vera, M ;

Saurina, A ;

Solé, M ;

Cervantes, F ;

Botey, A .

LEUKEMIA & LYMPHOMA, 2003, 44 (07) :1239-1241

[8]

Rougier P, 2004, J CLIN ONCOL, V22, p248S

[9]

Rubio ED, 2005, J CLIN ONCOL, V23, p254S

[10] Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor [J].

Saltz, LB ;

Meropol, NJ ;

Loehrer, PJ ;

Needle, MN ;

Kopit, J ;

Mayer, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1201-1208

← 1 2 →